In this study, we developed an innovative process for the nanoconversion of DTX (1) to a paclitaxel mimic (PTXm, 3) via selective cleavage of a peptide (Phe-Arg-Arg, FRR) by cathepsin B, which is prevalent in tumor environments. This evidence concerns the gene CTSB and neoplasm.